AMRN - Amarin Corporation plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
3.39
+0.11 (+3.35%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close3.28
Open3.32
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.27 - 3.42
52 Week Range2.81 - 4.47
Volume2,747,033
Avg. Volume1,272,747
Market Cap918.28M
Beta1.34
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube20 days ago

    ETFs with exposure to Amarin Corp. Plc : November 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Amarin Corp. Plc : November 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
    Capital Cubelast month

    Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Amarin Corp. Plc reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Amarin Corp. Plc – AbbVie, Inc., GlaxoSmithKline plc Sponsored ADR and Alkermes Plc (ABBV-US, GSK-US and ALKS-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of AMRN earnings conference call or presentation 1-Nov-17 12:00pm GMT

    Q3 2017 Amarin Corporation PLC Earnings Call

  • Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces 3Q:17 Financial Results and Provides Update on Operations
    SmarterAnalyst2 months ago

    Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces 3Q:17 Financial Results and Provides Update on Operations

    Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September 30, 2017, and provided an update on company operations. Product revenue growth: Recognized $47.1 million in U.S. net product revenue from Vascepa® (icosapent ethyl) sales in Q3 2017 compared to $32.4 million in Q3 2016, an increase of 45%. U.S. prescription growth: Increased normalized prescriptions for Vascepa by 44% compared to Q3 2016 based on data from both Symphony Health Solutions and QuintilesIMS.

  • Associated Press2 months ago

    Amarin reports 3Q loss

    The Dublin-based company said it had a loss of 4 cents per share. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss ...

  • Capital Cube2 months ago

    ETFs with exposure to Amarin Corp. Plc : October 23, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018
    Motley Fool2 months ago

    3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018

    If you're on the hunt for small-cap biotechs that could be big winners next year, Amarin, MannKind Corp., and 22nd Century Group need to be on your radar right now.

  • Capital Cube2 months ago

    ETFs with exposure to Amarin Corp. Plc : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Amarin Corp. Plc : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Amarin Corp. Plc : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Amarin Corp. Plc : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube4 months ago

    Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Amarin Corp. Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Amarin Corp. Plc – Ionis Pharmaceuticals, Inc., AbbVie, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Neptune Technologies & Bioressources Inc., Alkermes Plc and Astrazeneca ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of AMRN earnings conference call or presentation 2-Aug-17 12:00pm GMT

    Q2 2017 Amarin Corporation PLC Earnings Call

  • Zacks4 months ago

    Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?

    Investors in Amarin Corporation plc (AMRN) need to pay close attention to the stock based on moves in the options market lately.

  • Associated Press5 months ago

    Amarin reports 2Q loss

    On a per-share basis, the Dublin-based company said it had a loss of 5 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...

  • Here's Why Amarin Corporation plc Is on the Rise Today
    Motley Fool5 months ago

    Here's Why Amarin Corporation plc Is on the Rise Today

    Second-quarter Vascepa sales were even better than expected.

  • Here's Why Amarin Corporation plc Surged 34% Higher in June
    Motley Fool5 months ago

    Here's Why Amarin Corporation plc Surged 34% Higher in June

    A closer look at results from a trial with Vascepa encouraged investors.

  • Zacks6 months ago

    Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?

    Investors in Amarin Corporation plc (AMRN) need to pay close attention to the stock based on moves in the options market lately.

  • Capital Cube6 months ago

    ETFs with exposure to Amarin Corp. Plc : June 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • SmarterAnalyst6 months ago

    Cantor Pounds The Table On Amarin Corporation plc (ADR) (AMRN)

    Cantor analyst Louise Chen was out pounding the table on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), assuming an Overweight rating and price target of $10.00, which represents a potential upside of 190% from where the stock is currently trading.

  • 3 Cheap Healthcare Stocks You Can Buy Right Now
    Motley Fool6 months ago

    3 Cheap Healthcare Stocks You Can Buy Right Now

    Amarin, Horizon Pharma, and Valeant Pharmaceuticals may be downright bargains right now. Here's why.

  • Opening Bell, June 13, 2017
    CNBC Videos6 months ago

    Opening Bell, June 13, 2017

    Robert Toll, Toll Brothers executive chairman of the board, celebrating the company's 50th anniversary at the NYSE, and John Thero, Amarin Corporation CEO, at the Nasdaq, ring today's opening bells.

  • Today's Bell Ringer, June 13, 2017
    CNBC Videos6 months ago

    Today's Bell Ringer, June 13, 2017

    Today's bell ringers are Robert Toll, Toll Brothers executive chairman of the board, at the NYSE, and John Thero, Amarin Corporation CEO, at the Nasdaq.